Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Pharmacielo Ltd (PCLO.VN)

Pharmacielo Ltd (PCLO.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 30,669
  • Shares Outstanding, K 170,385
  • Annual Sales, $ 5,309 K
  • Annual Income, $ -14,516 K
  • 60-Month Beta 0.71
  • Price/Sales 9.19
  • Price/Cash Flow N/A
  • Price/Book 11.01
Trade PCLO.VN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.08
  • Most Recent Earnings $-0.02 on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    TSX Drug Specialty & Generic

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.160 +3.13%
on 04/22/24
0.290 -43.10%
on 04/04/24
-0.015 (-8.33%)
since 03/22/24
3-Month
0.130 +26.92%
on 03/18/24
0.290 -43.10%
on 04/04/24
-0.020 (-10.81%)
since 01/22/24
52-Week
0.105 +57.14%
on 08/21/23
0.290 -43.10%
on 04/04/24
-0.075 (-31.25%)
since 04/21/23

Most Recent Stories

More News
PharmaCielo Signs Binding Letter of Intent to Acquire Operations in Thailand; Announces $2 Million Non-Brokered Private Placement with Participation from PharmaCielo Insiders and Siam Ventures Investors

The proposed acquisition of Siam Ventures, which provides contract manufacturing services through a subsidiary, will act as a gateway to large Asian markets for PharmaCielo product.Experienced investor,...

PCLO.VN : 0.165 (-8.33%)
PharmaCielo to Supply Ease Labs with Commercial Shipments of API to Fulfill Contract with State Government of Sao Paulo, Brazil

The contract to supply the State of São Paulo is the largest public sector contract awarded to date in Brazil - the State of São Paulo is the largest state in the country. Ease Labs to supply up to 1.871...

PCLOF : 0.1239 (-3.20%)
PCLO.VN : 0.165 (-8.33%)
Colombian Government Continues its Support of Domestic Cannabis Industry - Resolution Extending THC Inventory Allowance Provides Immediate Benefit to PharmaCielo

Toronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - March 1, 2024) - PharmaCielo Ltd. (TSXV: PCLO) (OTCQX: PCLOF) ("PharmaCielo" or the "Company"), the Canadian parent of Colombia's premier cultivator...

PCLOF : 0.1239 (-3.20%)
PCLO.VN : 0.165 (-8.33%)
Benuvia and PharmaCielo Announce Strategic Partnership to Manufacture cGMP Pharmaceutical-Grade CBD Isolate and Related Products

Austin, Texas and Toronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - January 4, 2024) - Benuvia Operations, LLC ("Benuvia"), a FDA registered, DEA licensed and cGMP certified leader in pharmaceutical...

PCLOF : 0.1239 (-3.20%)
PCLO.VN : 0.165 (-8.33%)
PharmaCielo Announces Q3 2023 Financial Results

All figures in Canadian dollars ($) unless otherwise specifiedToronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - November 29, 2023) - PharmaCielo Ltd. (TSXV: PCLO) (OTCQX: PCLOF) ("PharmaCielo"...

PCLOF : 0.1239 (-3.20%)
PCLO.VN : 0.165 (-8.33%)
PharmaCielo Raises $3.3 Million Under Previously Announced Non-Brokered Private Placement

Today the Company closed the latest tranche consisting of 1,500 units for aggregate proceeds of $1,500,000.The Company also announced that it has agreed to issue shares and debt in settlement of certain...

PCLOF : 0.1239 (-3.20%)
PCLO.VN : 0.165 (-8.33%)
PharmaCielo Announces Q2 2023 Financial Results

All figures in Canadian dollars ($) unless otherwise specifiedToronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - August 29, 2023) - PharmaCielo Ltd. (TSXV: PCLO) (OTCQX: PCLOF) ("PharmaCielo" or...

PCLOF : 0.1239 (-3.20%)
PCLO.VN : 0.165 (-8.33%)
PharmaCielo Provides Corporate Update

Toronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - August 10, 2023) - PharmaCielo Ltd. (TSXV: PCLO) (OTCQX: PCLOF) ("PharmaCielo" or the "Company"), the Canadian parent of Colombia's premier cultivator...

PCLO.VN : 0.165 (-8.33%)
PCLOF : 0.1239 (-3.20%)
PharmaCielo Announces Appointment of Marc Lustig as Chairman and CEO

Toronto, Ontario and Rionegro, Colombia--(Newsfile Corp. - July 11, 2023) - PharmaCielo Ltd. (TSXV: PCLO) (OTCQX: PCLOF) ("PharmaCielo" or the "Company"), the Canadian parent of Colombia's premier cultivator...

PCLO.VN : 0.165 (-8.33%)
PharmaCielo Provides Corporate Update

PharmaCielo is actively working with more than 24 customers in 15 countries globally, with a focus on psychoactive APIs and dried flower.The Company recently made its first shipment of THC Distillate and...

PCLO.VN : 0.165 (-8.33%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakening short term outlook on maintaining the current direction.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

PharmaCielo Ltd is a pharma company, with a focus on ethical and sustainable processing and supplying of both THC(tetrahydrocannabinol) and CBD (cannabidiol) medicinal cannabis extracts. The company operates in Canada, Colombia, Italy, and Mexico. It generates the majority of the revenue in the form...

See More

Key Turning Points

3rd Resistance Point 0.188
2nd Resistance Point 0.182
1st Resistance Point 0.173
Last Price 0.165
1st Support Level 0.158
2nd Support Level 0.152
3rd Support Level 0.143

See More

52-Week High 0.290
Fibonacci 61.8% 0.219
Fibonacci 50% 0.197
Fibonacci 38.2% 0.176
Last Price 0.165
52-Week Low 0.105

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar